Media Coverage Report Lasa Supergenerics Ltd. lists on NSE Coverage Report.pdf · 2017-09-25 ·...
Transcript of Media Coverage Report Lasa Supergenerics Ltd. lists on NSE Coverage Report.pdf · 2017-09-25 ·...
Media Coverage Report
Lasa Supergenerics Ltd. lists on NSE
Prepared by
INDEX
Sr. No. Date Publication Edition Pg. No.
1 22-Sep-17 Financial Express Mumbai 13
2 22-Sep-17 Afternoon Despatch & Courier Mumbai 25
Regionals
3 22-Sep-17 Janpath Samachar Siliguri 11
4 22-Sep-17 Aadarsh Maharashtra Mumbai 04
Channels
5 21-Spe-17 ET Now National NA
6 21-Sep-17 CNBC Awaaz National NA
7 21-Sep-17 CNBC Bajar National NA
Online
8 21-Sep-17 The Economic Times
NA
9 21-Sep-17 Business Standard
NA
10 21-Sep-17 India Infoline
NA
11 21-Sep-17 Zeebiz
NA
12 21-Sep-17 Outlook India
NA
13 21-Sep-17 India Today
NA
14 21-Sep-17 India Today
NA
15 21-Sep-17 India.com
NA
16 21-Sep-17 Shafaqana
NA
17 21-Sep-17 Traders.com
NA
Publication : Financial Express Edition : Mumbai
Date : September 22, 2017 Page: 13
Publication : Afternoon Despatch & Courier Edition : Mumbai
Date : September 22, 2017 Page: 25
Publication : Janpath Samachar Edition : Siliguri
Date : September 22, 2017 Page: 11
Publication : Aadarsh Maharashtra Edition : Mumbai
Date : September 22, 2017 Page: 04
Channel : ET Now Edition : Electronic
Date : September 21, 2017 Page: NA
Channel : CNBC Awaaz Edition : Electronic
Date : September 21, 2017 Page: NA
Channel : CNBC Bajar Edition : Electronic
Date : September 21, 2017 Page: NA
Publication : The Economic Times Link :
http://economictimes.indiatimes.com/markets/s
tocks/news/lasa-supergenerics-lists-at-rs-140-20-
on-nse-omkar-speciality-drops-
5/articleshow/60775643.cms
Date : September 21, 2017
Lasa Supergenerics lists at Rs 140.20 on NSE; Omkar Speciality drops 5%
NEW DELHI: Shares of Lasa Supergenerics got listed at Rs 140.20 on NSE.
The stock of the demerger entity of Omkar SpecialityBSE -2.12 % later climbed 5 per cent to hit a high of Rs
147.20 on the stock exchange. Shares of Omkar Speciality Chemicals , on the other hand, dropped 4.5 per
cent to Rs 81.65, eventually closing at Rs 82.45, down 3.57 per cent.
Every shareholder holding a single share of Omkar Speciality Chemicals has got one share of LASA
Laboratories after the demerger. The record date was set at July 13
Omkar Speciality Chemicals, which has carried some investments in LASA Laboratories in the past, holds
around 10 per cent of the equity of LASA Laboratories post the demerger.
Omkar Speciality Chemicals is primarily engaged in the manufacture and sale of specialty chemicals and
intermediates for chemical and allied industries.
Publication : Business Standard Link : http://www.business-
standard.com/article/pti-stories/lasa-
supergenerics-lists-on-bourses-
117092101047_1.html
Date : September 21, 2017
Lasa Supergenerics lists on bourses
The equity shares of Lasa Supergenerics Ltd, a demerged entity of Omkar Speciality Chemicals Ltd (OSCL)
today got listed on the National Stock Exchange (NSE) and BSE.
Lasa group is a veterinary API manufacturing entity, which was acquired in April 2012 as a 100 per cent
subsidiary by OSCL.
As per the scheme of arrangement, Lasa Supergenerics has made allotment of 2,05,78,004 equity shares of
Rs 10 each to the shareholders of the OSCL in the ratio of 1 equity share of Rs 10 each of Lasa Supergenerics
for every share of Rs 10 each held by the shareholders of Omkar Speciality Chemicals.
"Going forward, we are looking at organic CAGR of 20-25 per cent and forward integration into formulations
business. The company posted a turnover of Rs 200 crore and aims to cross Rs 500 crore mark by 2020,"
Lasa Supergenerics chairman Omkar Herlekar told PTI here.
The company is also looking at increasing its footprint and targets 50 per cent of exports at Rs 250 crore by
2020, he said.
Publication : India Infoline Link :
http://www.indiainfoline.com/article/news-top-
story/lasa-supergenerics-breaches-upper-circuit-
omkar-speciality-down-117092100150_1.html
Date : September 21, 2017
Lasa Supergenerics breaches upper circuit, Omkar Speciality down
Demerged entity of Omkar Speciality, Lasa Supergenerics got its shares listed on the NSE at Rs 140.20 per
share on September 21, 2017.
Demerged entity of Omkar Speciality, Lasa Supergenerics got its shares listed on the NSE at Rs 140.20 per
share on September 21, 2017. Lasa Supergenerics surged by 5% on the NSE to hit a high of Rs 147.20 per
share on the stock exchange on Thursday.
Lasa Supergenerics hit an intraday high of Rs 147.20 per share and an intraday low of Rs 136 per share on
NSE on Thursday. The stock also breached its upper circuit. The stock recorded a trade volume of 7,96,802
shares and a trade value of Rs 1,152.49 lakh on NSE during the Thursday’s trade.
Meanwhile the share price of Omkar Speciality Chemicals fell by 4.5% to Rs 81.65 per share on the NSE
during Thursday’s trade. At 1132 hours, Omkar Speciality Chemicals was trading at Rs 83.05 per share, lower
by 2.29% on NSE on September 21, 2017.
Post the demerger, every shareholder holding one share of Omkar Speciality Chemicals was allotted one
share of Lasa Laboratories. Omkar Speciality Chemicals has around 10% of the equity of LASA Laboratories
after demerger.
Omkar Speciality Chemicals is primarily engaged in the manufacture and sale of Specialty chemicals and
intermediates for chemical and allied industries.
Publication : Zee Business Link : http://www.zeebiz.com/agencies/lasa-
supergenerics-lists-on-bourses-25517 Date : September 21, 2017
Lasa Supergenerics lists on bourses
The equity shares of Lasa Supergenerics Ltd, a demerged entity of Omkar Speciality Chemicals Ltd (OSCL)
today got listed on the National Stock Exchange (NSE) and BSE.
Lasa group is a veterinary API manufacturing entity, which was acquired in April 2012 as a 100 per cent
subsidiary by OSCL.
As per the scheme of arrangement, Lasa Supergenerics has made allotment of 2,05,78,004 equity shares of
Rs 10 each to the shareholders of the OSCL in the ratio of 1 equity share of Rs 10 each of Lasa Supergenerics
for every share of Rs 10 each held by the shareholders of Omkar Speciality Chemicals.
"Going forward, we are looking at organic CAGR of 20-25 per cent and forward integration into formulations
business. The company posted a turnover of Rs 200 crore and aims to cross Rs 500 crore mark by 2020,"
Lasa Supergenerics chairman Omkar Herlekar told
Publication : Outlook India Link :
https://www.outlookindia.com/newsscroll/lasa-
supergenerics-lists-on-bourses/1151470 Date : September 21, 2017
Lasa Supergenerics lists on bourses
Mumbai, Sep 21 The equity shares of Lasa Supergenerics Ltd, a demerged entity of Omkar Speciality
Chemicals Ltd (OSCL) today got listed on the National Stock Exchange (NSE) and BSE.
Lasa group is a veterinary API manufacturing entity, which was acquired in April 2012 as a 100 per cent
subsidiary by OSCL.
As per the scheme of arrangement, Lasa Supergenerics has made allotment of 2,05,78,004 equity shares of
Rs 10 each to the shareholders of the OSCL in the ratio of 1 equity share of Rs 10 each of Lasa Supergenerics
for every share of Rs 10 each held by the shareholders of Omkar Speciality Chemicals.
"Going forward, we are looking at organic CAGR of 20-25 per cent and forward integration into formulations
business. The company posted a turnover of Rs 200 crore and aims to cross Rs 500 crore mark by 2020,"
Lasa Supergenerics chairman Omkar Herlekar told PTI here.
The company is also looking at increasing its footprint and targets 50 per cent of exports at Rs 250 crore by
2020, he said.
Publication : India Today Link : http://indiatoday.intoday.in/story/lasa-
supergenerics-lists-on-bourses/1/1053162.html Date : September 21, 2017
Lasa Supergenerics lists on bourses
Mumbai, Sep 21 (PTI) The equity shares of Lasa Supergenerics Ltd, a demerged entity of Omkar Speciality
Chemicals Ltd (OSCL) today got listed on the National Stock Exchange (NSE) and BSE.
Lasa group is a veterinary API manufacturing entity, which was acquired in April 2012 as a 100 per cent
subsidiary by OSCL.
As per the scheme of arrangement, Lasa Supergenerics has made allotment of 2,05,78,004 equity shares of
Rs 10 each to the shareholders of the OSCL in the ratio of 1 equity share of Rs 10 each of Lasa Supergenerics
for every share of Rs 10 each held by the shareholders of Omkar Speciality Chemicals.
"Going forward, we are looking at organic CAGR of 20-25 per cent and forward integration into formulations
business. The company posted a turnover of Rs 200 crore and aims to cross Rs 500 crore mark by 2020,"
Lasa Supergenerics chairman Omkar Herlekar told PTI here.
The company is also looking at increasing its footprint and targets 50 per cent of exports at Rs 250 crore by
2020, he said.
Publication : India Today Link : http://indiatoday.intoday.in/story/lasa-
supergenerics-lists-on-bourses/1/1053218.html Date : September 21, 2017
Lasa Supergenerics lists on bourses
Mumbai, Sep 21 (PTI) The equity shares of Lasa Supergenerics Ltd, a demerged entity of Omkar Speciality
Chemicals Ltd (OSCL) today got listed on the National Stock Exchange (NSE) and BSE.
Lasa group is a veterinary API manufacturing entity, which was acquired in April 2012 as a 100 per cent
subsidiary by OSCL.
As per the scheme of arrangement, Lasa Supergenerics has made allotment of 2,05,78,004 equity shares of
Rs 10 each to the shareholders of the OSCL in the ratio of 1 equity share of Rs 10 each of Lasa Supergenerics
for every share of Rs 10 each held by the shareholders of Omkar Speciality Chemicals.
"Going forward, we are looking at organic CAGR of 20-25 per cent and forward integration into formulations
business. The company posted a turnover of Rs 200 crore and aims to cross Rs 500 crore mark by 2020,"
Lasa Supergenerics chairman Omkar Herlekar told PTI here.
The company is also looking at increasing its footprint and targets 50 per cent of exports at Rs 250 crore by
2020, he said.
Publication : India.com Link :
http://www.india.com/news/agencies/lasa-
supergenerics-lists-on-bourses-2488331/ Date : September 21, 2017
Lasa Supergenerics lists on bourses
Mumbai, Sep 21 (PTI) The equity shares of Lasa Supergenerics Ltd, a demerged entity of Omkar Speciality
Chemicals Ltd (OSCL) today got listed on the National Stock Exchange (NSE) and BSE.
Lasa group is a veterinary API manufacturing entity, which was acquired in April 2012 as a 100 per cent
subsidiary by OSCL.
As per the scheme of arrangement, Lasa Supergenerics has made allotment of 2,05,78,004 equity shares of
Rs 10 each to the shareholders of the OSCL in the ratio of 1 equity share of Rs 10 each of Lasa Supergenerics
for every share of Rs 10 each held by the shareholders of Omkar Speciality Chemicals.
“Going forward, we are looking at organic CAGR of 20-25 per cent and forward integration into formulations
business. The company posted a turnover of Rs 200 crore and aims to cross Rs 500 crore mark by 2020,”
Lasa Supergenerics chairman Omkar Herlekar told PTI here.
The company is also looking at increasing its footprint and targets 50 per cent of exports at Rs 250 crore by
2020, he said.
Publication : Shafaqna Link : http://in.shafaqna.com/EN/05582251
Date : September 21, 2017
Lasa Supergenerics lists on bourses
The equity shares of Lasa Supergenerics Ltd, a demerged entity of Omkar Speciality Chemicals Ltd (OSCL)
today got listed on the National Stock Exchange (NSE) and BSE. Lasa group is a veterinary API manufacturing
entity, which was acquired in April 2012
Publication : 4-Traders Link : http://www.4-traders.com/OMKAR-
SPECIALITY-CHEMICAL-9743872/news/Lasa-
Supergenerics-breaches-upper-circuit-Omkar-
Speciality-down-25153850/
Date : September 21, 2017
Lasa Supergenerics : breaches upper circuit, Omkar Speciality down
Demerged entity of Omkar Speciality, Lasa Supergenerics got its shares listed on the NSE at Rs 140.20 per
share on September 21, 2017. Demerged entity of Omkar Speciality, Lasa Supergenerics got its shares listed
on the NSE at Rs 140.20 per share on September 21, 2017. Lasa Supergenerics surged by 5% on the NSE to
hit a high of Rs 147.20 per share on the stock exchange on Thursday.
Lasa Supergenerics hit an intraday high of Rs 147.20 per share and an intraday low of Rs 136 per share on
NSE on Thursday. The stock also breached its upper circuit. The stock recorded a trade volume of 7,96,802
shares and a trade value of Rs 1,152.49 lakh on NSE during the Thursday’s trade.
Meanwhile the share price of Omkar Speciality Chemicals fell by 4.5% to Rs 81.65 per share on the NSE
during Thursday’s trade. At 1132 hours, Omkar Speciality Chemicals was trading at Rs 83.05 per share, lower
by 2.29% on NSE on September 21, 2017.
Post the demerger, every shareholder holding one share of Omkar Speciality Chemicals was allotted one
share of Lasa Laboratories. Omkar Speciality Chemicals has around 10% of the equity of LASA Laboratories
after demerger.
Omkar Speciality Chemicals is primarily engaged in the manufacture and sale of Specialty chemicals and
intermediates for chemical and allied industries.